Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-28

Clinical Trial Update: Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a combination of eniluracil, 5-fluorouracil, and oxaliplatin for advanced colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Eniluracil (eniluracil)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: NYU Langone Health | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED